Back to News
Market Impact: 0.35
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Source: benzinga.com
Healthcare & BiotechM&A & RestructuringCompany Fundamentals
Tempest Therapeutics shares rose sharply in pre-market trading after the clinical-stage biotechnology company announced an exclusive option agreement with Hebei Senlang Biotechnology. The agreement is a positive strategic-development catalyst for Tempest, although the article did not disclose financial terms, product assets, or expected revenue impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
TPST0.72
More News
- Companies promised AI gains— here's how the payoff showed up in earnings
- FBI blames North Korea for record $6.3bn crypto heist
- Binance to resume crypto withdrawals in phases after record $6 billion hack
- AWS grows 39% and Amazon will spend even more on AI in 2027
- SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution
- U.S workers just took home their smallest share of capital since at least 1947—and the lowest ever recorded